TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Moberg Pharma AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 207 | 0 | 50,488 |
Financial expenses | 72 | 240 | 2,598 |
Earnings before taxes | -19,512 | -19,970 | 13,433 |
EBITDA | -17,644 | -17,146 | 19,790 |
Total assets | 564,423 | 450,889 | 480,579 |
Current assets | 127,760 | 104,655 | 166,813 |
Current liabilities | 26,786 | 15,538 | 80,184 |
Equity capital | 533,584 | 434,051 | 387,870 |
- share capital | 9,827 | 4,405 | 1,818 |
Employees (average) | 8 | 8 | 11 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 94.5% | 96.3% | 80.7% |
Turnover per employee | 26 | 0 | 4,590 |
Profit as a percentage of turnover | -9426.1% | 26.6% | |
Return on assets (ROA) | -3.4% | -4.4% | 3.3% |
Current ratio | 477.0% | 673.5% | 208.0% |
Return on equity (ROE) | -3.7% | -4.6% | 3.5% |
Change turnover | 207 | -50,488 | 34,934 |
Change turnover % | -100% | 225% | |
Chg. No. of employees | 0 | -3 | -16 |
Chg. No. of employees % | 0% | -27% | -59% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.